Assyro AI

FDA Orange Book · active-ingredient family

Promazine hydrochloride

Promazine hydrochloride is approved as 3 brand and 2 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:SPARINE · NDA 010942

3

Brand (NDA)

2

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · concentrate, injectable, syrup, tablet

ProductApplicantApplicationTEApproved
SPARINE×3WYETH AYERSTNDA 010942Approved Prior to Jan 1, 1982
SPARINE×2HIKMANDA 010349Approved Prior to Jan 1, 1982
SPARINE×5WYETH AYERSTNDA 010348Approved Prior to Jan 1, 1982

Generic (ANDA) products (2)

ProductApplicantApplicationTEApproved
PROMAZINE HYDROCHLORIDEWATSON LABSANDA 084510Approved Prior to Jan 1, 1982
PROMAZINE HYDROCHLORIDEWATSON LABSANDA 084517Approved Prior to Jan 1, 1982

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Promazine hydrochloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.